The Phama Letter PharmaceuticalsPHARMACEUTICALS covers patent-protected prescription medicines, with news relating to drugmakers, their financial  performance, licensing, research and merger & acquisition activities. This also reports on health care markets, patent developments,  legislation, product approvals and delays around the globe, backed by a massive archive from which developments in all these areas can be tracked.

Latest Pharma Letter Articles

Pharmaceutical

features_upload

UK's NICE does U-turn, recommending Zytiga as Janssen cuts price

16 May 2012

UK drugs watch dog the National Institute for Health and Clinical Excellence (NICE) has reversed

Cornerstone makes $125 million, plus, bid for EKR Thera

16 May 2012

In a second acquisition move within a matter of months, USA-based specialty drugmaker Cornerstone

Amylin said to be attracting several Big Pharma suitors

16 May 2012

US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), which earlier this year rebuffed a $22

Call for EU law change to solve medicines shortage crisis

16 May 2012

A UK Parliamentary group has warned that patients are suffering because of a shortage of some

Biovest to file for EU approval of BiovaxID, a personalized cancer vaccine

16 May 2012

USA-based Biovest International (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals

Furiex Pharma gets rights to Priligy, some of which it sells on to Menarini

15 May 2012

In a two part transaction, USA-based Furiex Pharmaceuticals (Nasdaq: FURX) has entered into